Journal article · 2025 · Open access

A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy

Junying Ding, Xueze Zhao, Saran Long, Wen Ce Sun, Jianjun Du, Jiangli Fan, Xiaojun Peng

Smart Molecules, 3(3), e70014 · Published 19 August 2025 · DOI 10.1002/smo2.70014

Open PDFView at the publisherCite this paper

In brief

“A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy” is a 2025 journal article by Junying Ding and 6 co-authors, published in Smart Molecules. OpenAlex counts 19 citations as of 19 November 2026, which puts it in the top 7% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Smart Molecules.

Citations
19
Most cited in
2026 (17)
Field-weighted impact
3.36
References
39
Authors
7

Abstract

The clinical application of tumor vaccines is hindered by challenges such as time‐consuming and costly production processes. In this context, in situ cancer vaccines represent a promising strategy by leveraging endogenous tumor antigens to elicit robust antitumor T cell responses. Herein, a photoactivatable tumor‐targeting in situ nanovaccine, Lipo‐D8‐6, was constructed using cRGD‐functionalized liposomes that co‐encapsulated the photosensitizer chlorin e6 and a cleavable immunoadjuvant conjugate D8, allowing light‐triggered synchronous activation of three therapeutic modules. Upon near‐infrared light irradiation, Lipo‐D8‐6 generates reactive oxygen species that exert direct cytotoxicity on tumor cells and induce immunogenic cell death, while concurrently cleaving the responsive linker within D8 to achieve the controlled release of R848. In vivo biodistribution analysis confirmed the superior intratumoral accumulation of Lipo‐D8‐6, facilitating precise treatment. In a large‐volume tumor model, the nanovaccine exhibited pronounced antitumor efficacy, accompanied by enhanced tumor infiltration of CD8+ T cells. Overall, this work provides a simplified and effective approach for developing in situ nanovaccines that enable synergistic photodynamic immunotherapy with precise spatiotemporal control over immune activation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ding, J., Zhao, X., Long, S., Sun, W. C., Du, J., Fan, J., & Peng, X. (2025). A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy. Smart Molecules, 3(3), e70014. https://doi.org/10.1002/smo2.70014

MLA 9

Ding, Junying, et al. “A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy.” Smart Molecules, vol. 3, no. 3, 2025, p. e70014. https://doi.org/10.1002/smo2.70014.

Chicago

Ding, Junying, Xueze Zhao, Saran Long, Wen Ce Sun, Jianjun Du, Jiangli Fan, and Xiaojun Peng. 2025. “A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy.” Smart Molecules 3 (3): e70014. https://doi.org/10.1002/smo2.70014.

Harvard

Ding, J. et al. (2025) ‘A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy’, Smart Molecules, 3(3), p. e70014. doi:10.1002/smo2.70014.

IEEE

J. Ding et al., “A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy,” Smart Molecules, vol. 3, no. 3, p. e70014, 2025, doi: 10.1002/smo2.70014.

BibTeX

@article{ding2025photoactivatable,
  title     = {{A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy}},
  author    = {Ding, Junying and Zhao, Xueze and Long, Saran and Sun, Wen Ce and Du, Jianjun and Fan, Jiangli and Peng, Xiaojun},
  journal   = {Smart Molecules},
  year      = {2025},
  volume    = {3},
  number    = {3},
  pages     = {e70014},
  doi       = {10.1002/smo2.70014},
  url       = {https://doi.org/10.1002/smo2.70014}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics

  • photodynamic immunotherapy
  • chlorin e6
  • R848
  • immunoadjuvant
  • reactive oxygen species
  • immunogenic cell death
  • CD8+ T cell infiltration
  • near-infrared light

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Ding, J., Zhao, X., Long, S., Sun, W. C., Du, J., Fan, J., & Peng, X. (2025). A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy. Smart Molecules, 3(3), e70014. https://doi.org/10.1002/smo2.70014

How many times has this paper been cited?

19 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Smart Molecules: sign in and open the PDF from this page.

Who wrote this paper?

Junying Ding, Xueze Zhao, Saran Long, Wen Ce Sun, Jianjun Du, Jiangli Fan, Xiaojun Peng.

What is the DOI of this paper?

10.1002/smo2.70014, permanently at https://doi.org/10.1002/smo2.70014. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.